| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $19.71B | -1.7% |
| Cost of Revenue | $16.00B | -3.7% |
| Gross Profit | $962.0M | — |
| R&D Expense | $1.10B | -14.9% |
| SG&A Expense | $1.47B | +2.0% |
| Operating Income | $1.84B | +18.2% |
| Interest Expense | $337.0M | +18.2% |
| Pre-tax Income | $2.15B | +60.9% |
| Income Tax | $223.0M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.57B | -4.1% |
| Accounts Receivable | $3.26B | -8.0% |
| Inventory | $2.32B | -1.9% |
| Current Assets | $7.83B | -5.1% |
| Total Assets | $23.46B | -4.0% |
| Current Liabilities | $5.13B | +6.7% |
| Long-term Debt | $8.46B | +34.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $2.45B | +29.0% |
| Investing Cash Flow | -$507.0M | +49.4% |
| Financing Cash Flow | -$1.97B | -143.5% |
| +111.6% |
| Net Income | $1.79B | -39.2% |
| EPS (Basic) | $6.97 | -33.6% |
| EPS (Diluted) | $6.96 | -33.0% |
| Total Liabilities |
| $14.37B |
| +14.2% |
| Stockholders' Equity | $8.80B | -23.8% |